With increasing duration of diabetes, however, the counter-regulatory responses of first glucagon and then epinephrine wane, rendering the diabetic patient more vulnerable to severe hypoglycemia, whether it results from medications or other causes. This evidence concerns the gene GCG and diabetes mellitus.